Stritt, Kevin
Roth, Beat
Masnada, Audrey
Hammann, Felix
Jacot, Damien
Domingos-Pereira, Sonia
Crettenand, François
Bohner, Perrine
Sommer, Isabelle
Bréat, Emilien
Sauser, Julien
Derré, Laurent
Haschke, Manuel
Collins, James J.
McKinney, John
Meylan, Sylvain https://orcid.org/0000-0001-6319-2423
Funding for this research was provided by:
University of Lausanne
Article History
Received: 1 May 2024
Accepted: 1 October 2024
First Online: 15 October 2024
Declarations
:
: This clinical study adheres to Directive 2001/20/EC (Clinical Trials Directive) and has obtained approvals from the local ethics committee (CER-VD, 2023–01369, protocole V2.0) and the Swiss Agency for Therapeutic Products (Swissmedic, 701676). Patients will be enrolled after providing written informed consent. The study will follow international standards for Good Clinical Practice (GCP) and adhere to General Data Protection Regulation (GDPR) 679/2016 (EC). Insurance coverage is in place to address any potential harm resulting from participation. The authors emphasize the importance of timely dissemination of scientific findings through peer-reviewed open-access publications. Scientific events and symposiums will facilitate rapid dissemination and foster collaboration within the scientific community, ultimately ensuring widespread awareness and uptake of study outcomes.
: Not applicable.
: The authors declare that they have no competing interests.